home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

REMS Technology Innovation: Reducing Prescriber and Pharmacy Burden

 
  October 15, 2024  
     
 
Xtalks, Online
2024-11-06


Risk evaluation and mitigation strategy (REMS) programs were introduced as part of the 2007 FDA Administrations Amendment Act and may be used for certain drugs that have serious safety concerns to help ensure their benefits outweigh their risks.

If required, pharmaceutical companies must establish a REMS program by (1) agreeing to the goal and program requirements set by the US Food and Drug Administration (FDA), (2) establishing REMS implementation systems for stakeholders to conduct their required activities and (3) submitting REMS assessments to FDA.

REMS programs often require REMS stakeholders (Patients, Prescribers and Pharmacists) to complete transactions within the REMS implementation system to ensure that REMS activities have been fulfilled before the drug can be prescribed and/or dispensed. This activity is often performed outside of traditional healthcare workflow and systems, and therefore may increase stakeholder burden for participating in REMS programs.

Pharmaceutical companies, FDA and REMS industry partners have focused on addressing REMS stakeholder burden concerns through a variety of initiatives.

In this webinar, the expert speakers will examine the different REMS Health IT projects that are underway to address prescriber and pharmacy REMS stakeholder burden and look towards a more integrated, automated and aligned REMS implementation system approach.

Register for this webinar today to understand the evolving landscape of REMS programs and explore innovative health IT projects that are aimed at reducing the burden on prescribers and pharmacists.

Keywords: Pharmaceutical, Pharmaceutical Industry, Compounding Pharmacy, Pharmaceutical Marketing, Pharmacy, Risk-Based Monitoring, Risk Management, Regulatory, Risk Mitigation, Online Pharmacy
 
 
Organized by: Xtalks
Invited Speakers: Justin Wilson, Executive Director, Global Risk Management & REMS Technology Lead, Syneos Health
Brent Weyers, Director, Global Risk Management & REMS Implementation, Syneos Health
Matt Wright, Director, Specialty Pharmacovigilance and Product Safety, CVS Specialty
Jeff Deitch, CEO, InfoWerks Data Services
 
Deadline for Abstracts: 2024-11-06
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.